Executive Summary: Drug Delivery Markets, Vol. IV: Transdermal

Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market.

The report from which this Executive Summary is compiled is Drug Delivery Series, Volume 4, Transdermal/Transmucosal Delivery, and the full study abstract is as follows:

New biological treatments are being developed at a record place, but their potential could be compromised by significant obstacles to delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. New systems are being developed, and Kalorama's Drug Delivery Markets Series covers these new systems.

The fourth volume of this series, Kalorama's Drug Delivery Markets, Vol. IV: Transdermal and Transmucosal Drug Delivery is a complete overview of a delivery mechansim that offers some advantages: low pain, infection risk, fewer side effects and polonged delivery over time.